Immunicum submits IND application to the Food and Drug

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Immunicum submits IND application to the Food and Drug Administration (FDA) for approval to treat kidney cancer patients in the United States in its ongoing phase II-trial

Gothenburg, Sweden, July 22, 2016 - Immunicum AB (publ), a biopharmaceutical company pursuing to develop sophisticated, safe and efficient therapeutic cancer treatments with powerful and long lasting immune responses, today announced that the Company has submitted an Investigational New Drug (IND) application to the Food and Drug Administration (FDA) in the U.S. The application is requesting approval to treat kidney cancer patients in the U.S. with Immunicum's lead cancer immune primer, INTUVAX®, in its ongoing MERECA (MEtastatic REnal cell CArcinoma) phase II-trial.

Immunicum's INTUVAX® is a unique cancer immune primer currently being tested in clinical trials for the treatment of kidney cancer and liver cancer as well as GIST (gastrointestinal stromal tumor). As previously reported, results from Immunicum's completed phase I/II-trial for treatment of kidney cancer have been promising.

Today's announcement of the submission of the IND application to the FDA is one more step forward in the Company's clinical plans to expand it's testing of INTUVAX® into the U.S. Approval from the FDA is expected within 30 days.

For further information, please contact:

Jamal El-Mosleh, CEO, Immunicum

Phone: +46 (0) 31 41 50 52 jamal.el-mosleh@immunicum.com

The Company's Certified Adviser is Redeye AB Phone: +46 (0) 8 545 013 31. www.redeye.se

About INTUVAX

INTUVAX is a cancer immune primer, developed for the treatment of solid tumors. Its active ingredient is activated white blood cells, so called dendritic cells, derived from healthy blood donors. Intratumoral injection of these cells is expected to lead to an inflammatory response which in turn leads to tumor-specific activation of the patient's cytotoxic T lymphocytes.

About Immunicum AB (publ)

Immunicum AB (publ) is working to develop and advance cancer immune primers for the treatment of tumor diseases. A clinical phase II trial for the Company's most advanced product - INTUVAX® against kidney cancer - has been initiated. The project portfolio contains additional clinical phase I/II studies in liver cancer and in gastrointestinal stromal tumors (GIST).

For more information, please visit www.immunicum.com  

HUG#2030227

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 138

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 61

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 148

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 145

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 719

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 226

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Updated Category News Views 118

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 482

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 148

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 169

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading

Top 5 Most Recently Viewed Articles

Florida Housing Market Trends: Inventory Growth & Price Adjustments

Updated Category News Views 351

Florida's Evolving Housing Market Dynamics The housing market in Florida has recently been experiencing notable shifts. Inventory levels are up, and median sales prices are becoming more manageable, indicating significant changes in the market. According to the latest reports, the state is witnessing a transition toward equilibrium in its real estate sector. Current...

Continue Reading
Flor de Caña and Danil Nevsky Promote Sustainable Cocktails

Updated Category News Views 171

Flor de Caña and the Sustainable Cocktail Tour Flor de Caña, a prestigious name in the world of premium rums, has teamed up with Danil Nevsky, noted as one of the world's leading bartenders, to commence an exciting sustainable cocktail tour across the United States. This initiative focuses on blending cocktail culture with a commitment to environmental sustainability....

Continue Reading
Upcoming ARMOUR Residential REIT Webcast on Q3 Earnings

Updated Category News Views 163

ARMOUR Residential REIT's Upcoming Webcast ARMOUR Residential REIT, Inc. (NYSE: ARR) is poised to host a comprehensive webcast on its third-quarter 2025 operating results, scheduled for October 23, 2025. This conference call will provide insight into the company’s performance and strategic direction, connecting with equity analysts for an engaging discussion. Event...

Continue Reading
Kennametal Announces First Quarter Earnings Call Details

Updated Category News Views 142

Kennametal Inc. Earnings Conference Call Details Kennametal Inc. (NYSE: KMT) is excited to announce its upcoming earnings call for the first quarter of fiscal year 2026. Investors and analysts are invited to participate in this informative event, which will take place on a designated date in November. Attendees will find insightful discussions led by key executives of the...

Continue Reading
Radiance Technologies Expands Through Strategic Acquisition

Updated Category News Views 258

Radiance Technologies Expands Through Strategic Acquisition Radiance Technologies has made a significant move by acquiring Verus Research. This strategic acquisition aims to bolster its capabilities and broaden its customer base significantly. As a leader in providing innovative solutions to the Department of Defense and other sectors, the company's growth trajectory is...

Continue Reading